Abstract:While alternative methods for toxicity testing using re-constructed human skin and cornea have been written into guidelines and adopted by regulatory authorities, three-dimensional (3D) liver models are currently applied in the industrial settings for hepatotoxicity screening and prediction. These 3D liver models can recapitulate the architecture, functionality and toxicity response of the native liver, demonstrated by a set of related hallmarks. In this comprehensive review, non-scaffold and scaffold-based methods available for 3D liver model formation are introduced, with an emphasis on their advantages and drawbacks. We then focus on the characteristics of primary human hepatocytes, stem cell derived hepatocyte like cells, and immortalized hepatic cell lines as cell resources for model reconstruction. Primary hepatocytes are generally regarded to be superior to other cell types due to their comparable metabolic profiles to the native liver. Additionally, the application of 3D liver models (mostly liver spheroids) on the evaluation of drug induced liver injury and chronic liver diseases (steatosis, cirrhosis, cholestasis), as well as the potential of nanomaterials to introduce hepatotoxicity are summarized. Finally, the global 3D cell market from 3D liver model manufacturing to the contract service of <i>in vitro</i> hepatotoxicity testing using the models is extensively explored. However, 3D liver models face cultural and regulatory barriers in different countries, and therefore the business development of 3D liver models is not easy. Toxicologists, material scientists, engineers should work together to develop, validate and apply 3D liver models for hepatotoxicity testing under the support from industrial organizations and governmental agencies.

Liver organoid as a 3D in vitro model for drug validation and toxicity assessment

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

A Novel 3d Liver Organoid System for Elucidation of Hepatic Glucose Metabolism

Liver organoids: updates on generation strategies and biomedical applications

Liver organoids and their application in liver cancer research

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

The liver organoid's past, present and future: a personalized medicine strategy

Using Liver Organoids as Models to Study the Pathobiology of Rare Liver Diseases

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

Human liver organoids: From generation to applications

Three-dimensional cell culture model for hepatocytes opens a new avenue of real world research on liver

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

Development of novel tools for the in vitro investigation of drug-induced liver injury

Three-Dimensional Cell Co-Culture Liver Models and Their Applications in Pharmaceutical Research

Advances and Applications in Liver Organoid Technology

Generation of Multicellular 3D Liver Organoids From Induced Pluripotent Stem Cells as a Tool for Modelling Liver Diseases

Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids

Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer